Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Activated PI3K-delta Syndrome”

8 trials

Showing 8 of 8 results

Large-scale testing (Phase 3)Study completedNCT02435173
What this trial is testing

Study of Efficacy of CDZ173 in Patients With APDS/PASLI

Who this might be right for
Common Variable Immunodeficiency (CVID), APDS / PASLI
Novartis Pharmaceuticals 37
Large-scale testing (Phase 3)Ended earlyNCT02859727
What this trial is testing

Extension to the Study of Efficacy of CDZ173 in Patients with APDS/PASLI

Who this might be right for
Activated PI3Kdelta Syndrome (APDS); PASLI Disease
Pharming Technologies B.V. 37
Large-scale testing (Phase 3)Active Not RecruitingNCT05693129
What this trial is testing

Pediatric Patients Aged 1 to 6 Years With APDS

Who this might be right for
APDS
Pharming Technologies B.V. 16
Not applicableNot Yet RecruitingNCT06694363
What this trial is testing

New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase Δ Syndrome

Who this might be right for
Activated PI3K Delta Syndrome
Assistance Publique - Hôpitaux de Paris 14
Large-scale testing (Phase 3)Active Not RecruitingNCT05438407
What this trial is testing

Pediatric Patients Aged 4 to 11 Years With APDS

Who this might be right for
APDS
Pharming Technologies B.V. 15
Large-scale testing (Phase 3)UnknownNCT06249997
What this trial is testing

An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS

Who this might be right for
APDS Gene Mutation
Pharming Technologies B.V. 3
Testing effectiveness (Phase 2)Study completedNCT02593539
What this trial is testing

Safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Repeat Doses of Inhaled Nemiralisib in Patients With APDS/PASLI

Who this might be right for
Activated PI3K-delta Syndrome
GlaxoSmithKline 5
Testing effectiveness (Phase 2)Study completedNCT03383380
What this trial is testing

Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome

Who this might be right for
Activated PI3K-delta SyndromeImmunodeficiency Primary
Children's Hospital of Fudan University 30

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation